The 1990s is the decade known for bright colors, grunge music, and Saturday morning cartoons. It's the subject of nostalgia on television, cinema, and even in fashion. It's got fondly remembered ...

Get Instant Summarized Text (Gist) Pulmonary artery denervation (PADN) shows promise as an intervention for pulmonary hypertension, improving key hemodynamic parameters and clinical outcomes. A ...

Pulmonary artery denervation has become a promising therapeutic intervention in the management of pulmonary hypertension. While our findings suggest a substantial role for PADN in treatment ...

The patient, who was on the verge of death due to pulmonary edema (a buildup of fluid ... in two major coronary arteries through the radial artery on the arm on the patient within 30 to 45 minutes.

Background The vertebral artery (VA) ostium (VAO) is a common stenosis site. Most patients with VAO stenosis refractory to medical treatment are treated endovascularly using stenting. To optimally ...

Main pulmonary artery (MPA) diameter is a prognostic indicator in patients with pulmonary arterial hypertension (PAH) without congenital heart disease, according to study findings published in Chest.

There is no easy way to unclog an artery once plaque has built up. However, dietary choices, exercise, and avoiding smoking can improve cardiovascular health and stop blockages from worsening.

The investigator-led study enrolled 50 patients undergoing routine right heart catheterization (RHC), with CPS successfully measuring mean pulmonary artery pressure (mPAP) in 40 subjects.

Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

The HOST-BR trial demonstrated that for patients at either high or low risk of bleeding, 3 months is the optimal duration of treatment to reduce adverse events without increasing bleeding risk ...